Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis

Journal of Proteomics

Volumn 75, Issue 7, 2012, Pages 1991-2014

  Wu, Chieh Lin ^a   Chou, Hsiu Chuan ^a   Cheng, Chao Sheng ^a   Li, Ji Min ^a   Lin, Szu Ting ^a   Chen, Yi Wen ^a   Chan, Hong Lin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

DIGE; MALDI TOF; Proteomics; Redox; Skin fibroblasts; UVB

Indexed keywords

ALPHA TROPOMYOSIN; ARGONAUTE 1 PROTEIN; CALRETICULIN; COFILIN 1; CYSTEINE; CYTOKERATIN 1; CYTOKERATIN 16; CYTOPLASMIC DYNEIN; ELONGATION FACTOR 1; FK 506 BINDING PROTEIN; HEAT SHOCK PROTEIN 27; INTERSTITIAL COLLAGENASE; LIPOCORTIN 2; LIPOCORTIN 5; LYSINE; NUCLEOPHOSMIN; PEROXIREDOXIN 1; PEROXIREDOXIN 4; PEROXIREDOXIN 6; PROHIBITIN; PURINE NUCLEOSIDE PHOSPHORYLASE; THIOL; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; CELL VIABILITY; CYTOPLASM; CYTOSKELETON; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOGENESIS; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PHOTOAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEOMICS; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ULTRAVIOLET B RADIATION;

CELL LINE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; PROTEOLYSIS; PROTEOMICS; REACTIVE OXYGEN SPECIES; SKIN; SKIN NEOPLASMS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ULTRAVIOLET RAYS;

EID: 84862777202     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.12.038     Document Type: Article

References (88)

1. Ibuki Y., Naitou H., Ohashi N., Goto R. Proteome analysis of UV-B-induced anti-apoptotic regulatory factors. Photochem Photobiol 2005, 81:823-829.
2. Lee E., Koo J., Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol 2005, 44:355-360.
3. de Gruijl F.R. p53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects. Exp Dermatol 2002, 11(Suppl. 1):37-39.
4. Heck D.E., Gerecke D.R., Vetrano A.M., Laskin J.D. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol Appl Pharmacol 2004, 195:288-297.
5. Ashida M., Bito T., Budiyanto A., Ichihashi M., Ueda M. Involvement of EGF receptor activation in the induction of cyclooxygenase-2 in HaCaT keratinocytes after UVB. Exp Dermatol 2003, 12:445-452.
6. Madson J.G., Lynch D.T., Tinkum K.L., Putta S.K., Hansen L.A. Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation. Am J Pathol 2006, 169:1402-1414.
7. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem J 2007, 401:1-11.
8. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
9. D'Autreaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007, 8:813-824.
10. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995, 358:1-3.
11. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001, 30:1191-1212.
12. Lim J.C., Choi H.I., Park Y.S., Nam H.W., Woo H.A., Kwon K.S., et al. Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity. J Biol Chem 2008, 283:28873-28880.
13. Jacob C., Holme A.L., Fry F.H. The sulfinic acid switch in proteins. Org Biomol Chem 2004, 2:1953-1956.
14. Herbert B.R., Harry J.L., Packer N.H., Gooley A.A., Pedersen S.K., Williams K.L. What place for polyacrylamide in proteomics?. Trends Biotechnol 2001, 19:3-9.
15. Rabilloud T. Two-dimensional electrophoresis of basic proteins with equilibrium isoelectric focusing in carrier ampholyte-pH gradients. Electrophoresis 1994, 15:278-282.
16. Hung P.H., Chen Y.W., Cheng K.C., Chou H.C., Lyu P.C., Lu Y.C., et al. Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis. Mol Biosyst 2011, 7:1990-1998.
17. Huang H.L., Hsing H.W., Lai T.C., Chen Y.W., Lee T.R., Chan H.T., et al. Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci 2010, 17:36.
18. Lai T.C., Chou H.C., Chen Y.W., Lee T.R., Chan H.T., Shen H.H., et al. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J Proteome Res 2010, 9:1302-1322.
19. Chen Y.W., Chou H.C., Lyu P.C., Yin H.S., Huang F.L., Chang W.S., et al. Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. Funct Integr Genomics 2011, 11:225-239.
20. Chou H.C., Chen Y.W., Lee T.R., Wu F.S., Chan H.T., Lyu P.C., et al. Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia reperfusion injury and treatment. Free Radic Biol Med 2010, 49:96-108.
21. Perluigi M., Giorgi A., Blarzino C., De Marco F., Foppoli C., Di Domenico F., et al. Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation. J Cell Mol Med 2009, 13:1809-1822.
22. Chen Y.W., Liu J.Y., Lin S.T., Li J.M., Huang S.H., Chen J.Y., et al. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells. Mol Biosyst 2011, 7:3065-3074.
23. Chan H.L., Gaffney P.R., Waterfield M.D., Anderle H., Peter M.H., Schwarz H.P., et al. Proteomic analysis of UVC irradiation-induced damage of plasma proteins: serum amyloid P component as a major target of photolysis. FEBS Lett 2006, 580:3229-3236.
24. Chan H.L., Gharbi S., Gaffney P.R., Cramer R., Waterfield M.D., Timms J.F. Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics 2005, 5:2908-2926.
25. Timms J.F., Cramer R. Difference gel electrophoresis. Proteomics 2008, 8:4886-4897.
26. Enk C.D., Shahar I., Amariglio N., Rechavi G., Kaminski N., Hochberg M. Gene expression profiling of in vivo UVB-irradiated human epidermis. Photodermatol Photoimmunol Photomed 2004, 20:129-137.
27. Howell B.G., Wang B., Freed I., Mamelak A.J., Watanabe H., Sauder D.N. Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1. J Dermatol Sci 2004, 34:185-194.
28. Bertrand-Vallery V., Belot N., Dieu M., Delaive E., Ninane N., Demazy C., et al. Proteomic profiling of human keratinocytes undergoing UVB-induced alternative differentiation reveals TRIpartite Motif Protein 29 as a survival factor. PLoS One 2010, 5:e10462.
29. Ghezzi P., Bonetto V., Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 2005, 7:964-972.
30. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999, 6:99-104.
31. Wu M.H., Yung B.Y. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J Biol Chem 2002, 277:48234-48240.
32. Sears R., Leone G., DeGregori J., Nevins J.R. Ras enhances Myc protein stability. Mol Cell 1999, 3:169-179.
33. Yung B.Y. Oncogenic role of nucleophosmin/B23. Chang Gung Med J 2007, 30:285-293.
34. Maiguel D.A., Jones L., Chakravarty D., Yang C., Carrier F. Nucleophosmin sets a threshold for p53 response to UV radiation. Mol Cell Biol 2004, 24:3703-3711.
35. Colombo E., Alcalay M., Pelicci P.G. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene 2011, 30:2595-2609.
36. Korgaonkar C., Hagen J., Tompkins V., Frazier A.A., Allamargot C., Quelle F.W., et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 2005, 25:1258-1271.
37. Lin C.Y., Liang Y.C., Yung B.Y. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB. Cell Signal 2006, 18:2041-2048.
38. Rohde M., Daugaard M., Jensen M.H., Helin K., Nylandsted J., Jaattela M. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 2005, 19:570-582.
39. Morimoto R.I., Sarge K.D., Abravaya K. Transcriptional regulation of heat shock genes. A paradigm for inducible genomic responses. J Biol Chem 1992, 267:21987-21990.
40. Li H., Liu L., Xing D., Chen W.R. Inhibition of the JNK/Bim pathway by Hsp70 prevents Bax activation in UV-induced apoptosis. FEBS Lett 2010, 584:4672-4678.
41. Perluigi M., Di Domenico F., Blarzino C., Foppoli C., Cini C., Giorgi A., et al. Effects of UVB-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: a proteomic approach. Proteome Sci 2010, 8:13.
42. Hacki J., Egger L., Monney L., Conus S., Rosse T., Fellay I., et al. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 2000, 19:2286-2295.
43. Mera K., Kawahara K., Tada K., Kawai K., Hashiguchi T., Maruyama I., et al. ER signaling is activated to protect human HaCaT keratinocytes from ER stress induced by environmental doses of UVB. Biochem Biophys Res Commun 2010, 397:350-354.
44. Hashida T., Kotake Y., Ohta S. Protein disulfide isomerase knockdown-induced cell death is cell-line-dependent and involves apoptosis in MCF-7 cells. J Toxicol Sci 2011, 36:1-7.
45. Lovat P.E., Corazzari M., Armstrong J.L., Martin S., Pagliarini V., Hill D., et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 2008, 68:5363-5369.
46. Goplen D., Wang J., Enger P.O., Tysnes B.B., Terzis A.J., Laerum O.D., et al. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 2006, 66:9895-9902.
47. Nakamura K., Bossy-Wetzel E., Burns K., Fadel M.P., Lozyk M., Goping I.S., et al. Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J Cell Biol 2000, 150:731-740.
48. Kim I.S., Kim H.Y., Shin S.Y., Kim Y.S., Lee D.H., Park K.M., et al. A cyclophilin A CPR1 overexpression enhances stress acquisition in Saccharomyces cerevisiae. Mol Cells 2010, 29:567-574.
49. Lee J. Role of cyclophilin a during oncogenesis. Arch Pharm Res 2010, 33:181-187.
50. Choi K.J., Piao Y.J., Lim M.J., Kim J.H., Ha J., Choe W., et al. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Res 2007, 67:3654-3662.
51. Jin Z.G., Melaragno M.G., Liao D.F., Yan C., Haendeler J., Suh Y.A., et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000, 87:789-796.
52. Obchoei S., Wongkhan S., Wongkham C., Li M., Yao Q., Chen C. Cyclophilin A: potential functions and therapeutic target for human cancer. Med Sci Monit 2009, 15:RA221-RA232.
53. Doyle V., Virji S., Crompton M. Evidence that cyclophilin-A protects cells against oxidative stress. Biochem J 1999, 341(Pt 1):127-132.
54. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., Yodoi J. Redox control of cell death. Antioxid Redox Signal 2002, 4:405-414.
55. Zhang B., Wang Y., Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett 2009, 286:154-160.
56. Osman C., Merkwirth C., Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 2009, 122:3823-3830.
57. Merkwirth C., Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009, 1793:27-32.
58. Schleicher M., Shepherd B.R., Suarez Y., Fernandez-Hernando C., Yu J., Pan Y., et al. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 2008, 180:101-112.
59. Czarnecka A.M., Campanella C., Zummo G., Cappello F. Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol Ther 2006, 5:714-720.
60. Rajalingam K., Wunder C., Brinkmann V., Churin Y., Hekman M., Sievers C., et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 2005, 7:837-843.
61. Han E.K., Mcgonigal T., Butler C., Giranda V.L., Luo Y. Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells. Anticancer Res 2008, 28:957-963.
62. Mishra S., Ande S.R., Nyomba B.L. The role of prohibitin in cell signaling. FEBS J 2010, 277:3937-3946.
63. Ande S.R., Mishra S. Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2). Biochem Cell Biol 2010, 88:553-558.
64. Tong X., Zhao F., Thompson C.B. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 2009, 19:32-37.
65. Xing P., Li J.G., Jin F., Zhao T.T., Liu Q., Dong H.T., et al. Fascin, an actin-bundling protein, promotes breast cancer progression in vitro. Cell Biochem Funct 2011, 29:303-310.
66. Steeg P.S., Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 2008, 5:206-219.
67. Pollard T.D., Cooper J.A. Actin, a central player in cell shape and movement. Science 2009, 326:1208-1212.
68. Qualtrough D., Singh K., Banu N., Paraskeva C., Pignatelli M. The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer 2009, 101:1124-1129.
69. Tsai C.H., Chiu S.J., Liu C.C., Sheu T.J., Hsieh C.H., Keng P.C., et al. Regulated expression of cofilin and the consequent regulation of p27(kip1) are essential for G(1) phase progression. Cell Cycle 2009, 8:2365-2374.
70. Nowak D., Mazur A.J., Popow-Wozniak A., Radwanska A., Mannherz H.G., Malicka-Blaszkiewicz M. Subcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potential. Eur J Histochem 2010, 54:e14.
71. Hensbergen P., Alewijnse A., Kempenaar J., van der Schors R.C., Balog C.A., Deelder A., et al. Proteomic profiling identifies an UV-induced activation of cofilin-1 and destrin in human epidermis. J Invest Dermatol 2005, 124:818-824.
72. Klamt F., Zdanov S., Levine R.L., Pariser A., Zhang Y., Zhang B., et al. Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 2009, 11:1241-1246.
73. Jockusch B.M., Murk K., Rothkegel M. The profile of profilins. Rev Physiol Biochem Pharmacol 2007, 159:131-149.
74. 2-treated actin: assembly and polymer interactions with cross-linking proteins. Biophys J 1995, 69:2710-2719.
75. Dalle-Donne I., Giustarini D., Rossi R., Colombo R., Milzani A. Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 2003, 34:23-32.
76. Zwaenepoel I., Mustapha M., Leibovici M., Verpy E., Goodyear R., Liu X.Z., et al. Otoancorin, an inner ear protein restricted to the interface between the apical surface of sensory epithelia and their overlying acellular gels, is defective in autosomal recessive deafness DFNB22. Proc Natl Acad Sci U S A 2002, 99:6240-6245.
77. Schmidt D., Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci 2003, 60:2561-2574.
78. Coccia E.M., Stellacci E., Orsatti R., Benedetti E., Giacomini E., Marziali G., et al. Protein inhibitor of activated signal transducer and activator of transcription (STAT)-1 (PIAS-1) regulates the IFN-gamma response in macrophage cell lines. Cell Signal 2002, 14:537-545.
79. Starr R., Hilton D.J. Negative regulation of the JAK/STAT pathway. Bioessays 1999, 21:47-52.
80. Carbia-Nagashima A., Arzt E. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling. IUBMB Life 2004, 56:83-88.
81. Galanty Y., Belotserkovskaya R., Coates J., Polo S., Miller K.M., Jackson S.P. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009, 462:935-939.
82. Liu B., Yang R., Wong K.A., Getman C., Stein N., Teitell M.A., et al. Negative regulation of NF-kappaB signaling by PIAS1. Mol Cell Biol 2005, 25:1113-1123.
83. Chen C.L., Liou S.F., Chen S.J., Shih M.F. Protective effects of Chlorella-derived peptide on UVB-induced production of MMP-1 and degradation of procollagen genes in human skin fibroblasts. Regul Toxicol Pharmacol 2011, 60:112-119.
84. Masaki H. Role of antioxidants in the skin: anti-aging effects. J Dermatol Sci 2010, 58:85-90.
85. Kim S., Kim Y., Lee Y., Chung J.H. Ceramide accelerates ultraviolet-induced MMP-1 expression through JAK1/STAT-1 pathway in cultured human dermal fibroblasts. J Lipid Res 2008, 49:2571-2581.
86. Yamashita Y., Hoshino T., Matsuda M., Kobayashi C., Tominaga A., Nakamura Y., et al. HSP70 inducers from Chinese herbs and their effect on melanin production. Exp Dermatol 2010, 19:e340-e342.
87. Tanaka K., Asamitsu K., Uranishi H., Iddamalgoda A., Ito K., Kojima H., et al. Protecting skin photoaging by NF-kappaB inhibitor. Curr Drug Metab 2010, 11:431-435.
88. Jonak C., Klosner G., Trautinger F. Heat shock proteins in the skin. Int J Cosmet Sci 2006, 28:233-241.